Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2003 Oct;58(10):846–850. doi: 10.1136/thorax.58.10.846

Underdiagnosed asthma in South Australia

R Adams 1, D Wilson 1, S Appleton 1, A Taylor 1, G Dal 1, C Chittleborough 1, R Ruffin 1
PMCID: PMC1746482  PMID: 14514934

Abstract

Background: The prevalence of undiagnosed asthma in the general population and the clinical and demographic characteristics of these patients compared with those with diagnosed asthma are unclear.

Methods: The North West Adelaide Health Survey (NWAHS) is a population household interview survey of adults (age >18 years) in the north western suburbs of Adelaide, South Australia (regional population 0.6 million). Data obtained were weighted to the closest census data to provide population representative estimates. Positive answers to: "Have you ever had asthma?"; "Has it been confirmed by a doctor?"; "Do you still have asthma?" determined current physician diagnosed asthma. A positive bronchodilator response on spirometric testing according to ATS criteria without a physician's diagnosis determined undiagnosed asthma. Other measures included the SF-12 health survey questionnaire, the Selim index of severity of chronic lung disease, skin allergy tests, and demographic data.

Results: Of the 3422 individuals interviewed, 2523 (74%) agreed to participate in the clinical assessment. Of these, 292 (11.6%) had asthma, 236 (9.3%) with a doctor's diagnosis of asthma and 56 (2.3%) with undiagnosed asthma defined on spirometric criteria; thus, 19.2% of the total asthma group were undiagnosed. Those undiagnosed were more likely (p<0.05) to be >40 years old, on government benefits, with an income <AUD$40 000. Symptom frequency was similar in the two asthma groups, but mean spirometric values were lower in the undiagnosed group (p<0.05) while positive skin allergy tests were more common in the diagnosed group (p<0.05). SF-12 component summary scores were significantly lower in both asthma groups than in the non-asthma population. Undiagnosed asthma was frequent in men and in those aged >65 years. Health service use over the previous year was similar for both asthma groups.

Conclusion: Undiagnosed asthma is common among the Australian population, with a similar clinical spectrum to those with diagnosed asthma.

Full Text

The Full Text of this article is available as a PDF (218.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams R., Ruffin R., Wakefield M., Campbell D., Smith B. Asthma prevalence, morbidity and management practices in South Australia, 1992-1995. Aust N Z J Med. 1997 Dec;27(6):672–679. doi: 10.1111/j.1445-5994.1997.tb00997.x. [DOI] [PubMed] [Google Scholar]
  2. Ballard R. D., Clover C. W., Suh B. Y. Influence of sleep on respiratory function in emphysema. Am J Respir Crit Care Med. 1995 Apr;151(4):945–951. doi: 10.1164/ajrccm.151.4.7697271. [DOI] [PubMed] [Google Scholar]
  3. Banerjee D. K., Lee G. S., Malik S. K., Daly S. Underdiagnosis of asthma in the elderly. Br J Dis Chest. 1987 Jan;81(1):23–29. doi: 10.1016/0007-0971(87)90104-5. [DOI] [PubMed] [Google Scholar]
  4. Barnes P. J., Belvisi M. G., Mak J. C., Haddad E. B., O'Connor B. Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease. Life Sci. 1995;56(11-12):853–859. doi: 10.1016/0024-3205(95)00020-7. [DOI] [PubMed] [Google Scholar]
  5. Beam W. R., Weiner D. E., Martin R. J. Timing of prednisone and alterations of airways inflammation in nocturnal asthma. Am Rev Respir Dis. 1992 Dec;146(6):1524–1530. doi: 10.1164/ajrccm/146.6.1524. [DOI] [PubMed] [Google Scholar]
  6. Becker H. F., Piper A. J., Flynn W. E., McNamara S. G., Grunstein R. R., Peter J. H., Sullivan C. E. Breathing during sleep in patients with nocturnal desaturation. Am J Respir Crit Care Med. 1999 Jan;159(1):112–118. doi: 10.1164/ajrccm.159.1.9803037. [DOI] [PubMed] [Google Scholar]
  7. Belousova E. G., Haby M. M., Xuan W., Peat J. K. Factors that affect normal lung function in white Australian adults. Chest. 1997 Dec;112(6):1539–1546. doi: 10.1378/chest.112.6.1539. [DOI] [PubMed] [Google Scholar]
  8. Borsboom G. J., van Pelt W., van Houwelingen H. C., van Vianen B. G., Schouten J. P., Quanjer P. H. Diurnal variation in lung function in subgroups from two Dutch populations: consequences for longitudinal analysis. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1163–1171. doi: 10.1164/ajrccm.159.4.9703106. [DOI] [PubMed] [Google Scholar]
  9. Boushey H. A. Glucocorticoid therapy for chronic obstructive pulmonary disease. N Engl J Med. 1999 Jun 24;340(25):1990–1991. doi: 10.1056/NEJM199906243402509. [DOI] [PubMed] [Google Scholar]
  10. Brand P. L., Postma D. S., Kerstjens H. A., Koëter G. H. Relationship of airway hyperresponsiveness to respiratory symptoms and diurnal peak flow variation in patients with obstructive lung disease. The Dutch CNSLD Study Group. Am Rev Respir Dis. 1991 May;143(5 Pt 1):916–921. doi: 10.1164/ajrccm/143.5_Pt_1.916. [DOI] [PubMed] [Google Scholar]
  11. Casale R., Pasqualetti P. Cosinor analysis of circadian peak expiratory flow variability in normal subjects, passive smokers, heavy smokers, patients with chronic obstructive pulmonary disease and patients with interstitial lung disease. Respiration. 1997;64(4):251–256. doi: 10.1159/000196682. [DOI] [PubMed] [Google Scholar]
  12. Cochrane G. M., Clark J. H. A survey of asthma mortality in patients between ages 35 and 64 in the Greater London hospitals in 1971. Thorax. 1975 Jun;30(3):300–305. doi: 10.1136/thx.30.3.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Coe C. I., Barnes P. J. Reduction of nocturnal asthma by an inhaled anticholinergic drug. Chest. 1986 Oct;90(4):485–488. doi: 10.1378/chest.90.4.485. [DOI] [PubMed] [Google Scholar]
  14. Connolly M. J., Kelly C., Walters E. H., Hendrick D. J. An assessment of methacholine inhalation tests in elderly asthmatics. Age Ageing. 1988 Mar;17(2):123–128. doi: 10.1093/ageing/17.2.123. [DOI] [PubMed] [Google Scholar]
  15. Coultas D. B., Mapel D., Gagnon R., Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med. 2001 Aug 1;164(3):372–377. doi: 10.1164/ajrccm.164.3.2004029. [DOI] [PubMed] [Google Scholar]
  16. Crockett A. Screening older patients for obstructive airways disease. Thorax. 1999 Jun;54(6):472–473. doi: 10.1136/thx.54.6.472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Dawkins K. D., Muers M. F. Diurnal variation in airflow obstruction in chronic bronchitis. Thorax. 1981 Aug;36(8):618–621. doi: 10.1136/thx.36.8.618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Di Stefano A., Lusuardi M., Braghiroli A., Donner C. F. Nocturnal asthma: mechanisms and therapy. Lung. 1997;175(1):53–61. doi: 10.1007/pl00007556. [DOI] [PubMed] [Google Scholar]
  19. Dickinson J. A., Meaker M., Searle M., Ratcliffe G. Screening older patients for obstructive airways disease in a semi-rural practice. Thorax. 1999 Jun;54(6):501–505. doi: 10.1136/thx.54.6.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Disse B. Antimuscarinic treatment for lung diseases from research to clinical practice. Life Sci. 2001 Apr 27;68(22-23):2557–2564. doi: 10.1016/s0024-3205(01)01052-9. [DOI] [PubMed] [Google Scholar]
  21. Disse B., Speck G. A., Rominger K. L., Witek T. J., Jr, Hammer R. Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. Life Sci. 1999;64(6-7):457–464. doi: 10.1016/s0024-3205(98)00588-8. [DOI] [PubMed] [Google Scholar]
  22. Dow L., Fowler L., Phelps L., Waters K., Coggon D., Kinmonth A. L., Holgate S. T. Prevalence of untreated asthma in a population sample of 6000 older adults in Bristol, UK. Thorax. 2001 Jun;56(6):472–476. doi: 10.1136/thorax.56.6.472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Garratt A. M., Ruta D. A., Abdalla M. I., Buckingham J. K., Russell I. T. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ. 1993 May 29;306(6890):1440–1444. doi: 10.1136/bmj.306.6890.1440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Guberan E., Williams M. K., Walford J., Smith M. M. Circadian variation of F.E.V. in shift workers. Br J Ind Med. 1969 Apr;26(2):121–125. doi: 10.1136/oem.26.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Haahtela T., Järvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., Nikander K., Persson T., Reinikainen K., Selroos O. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991 Aug 8;325(6):388–392. doi: 10.1056/NEJM199108083250603. [DOI] [PubMed] [Google Scholar]
  26. Hahn D. L., Beasley J. W. Diagnosed and possible undiagnosed asthma: a Wisconsin Research Network (WReN) Study. Wisconsin Research Network (WReN) Asthma Prevalence Study Group. J Fam Pract. 1994 Apr;38(4):373–379. [PubMed] [Google Scholar]
  27. Hetzel M. R. The pulmonary clock. Thorax. 1981 Jul;36(7):481–486. doi: 10.1136/thx.36.7.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Higgins B. G., Britton J. R., Chinn S., Cooper S., Burney P. G., Tattersfield A. E. Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiologic studies. Am Rev Respir Dis. 1992 Mar;145(3):588–593. doi: 10.1164/ajrccm/145.3.588. [DOI] [PubMed] [Google Scholar]
  29. Isoaho R., Puolijoki H., Huhti E., Kivelä S. L., Laippala P., Tala E. Prevalence of chronic obstructive pulmonary disease in elderly Finns. Respir Med. 1994 Sep;88(8):571–580. doi: 10.1016/s0954-6111(05)80004-6. [DOI] [PubMed] [Google Scholar]
  30. Janson C., Chinn S., Jarvis D., Burney P. Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey. Eur Respir J. 1997 Aug;10(8):1795–1802. doi: 10.1183/09031936.97.10081795. [DOI] [PubMed] [Google Scholar]
  31. Kazis L. E., Anderson J. J., Meenan R. F. Effect sizes for interpreting changes in health status. Med Care. 1989 Mar;27(3 Suppl):S178–S189. doi: 10.1097/00005650-198903001-00015. [DOI] [PubMed] [Google Scholar]
  32. Knuiman M. W., James A. L., Divitini M. L., Ryan G., Bartholomew H. C., Musk A. W. Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol. 1999 Jul;9(5):297–306. doi: 10.1016/s1047-2797(98)00066-0. [DOI] [PubMed] [Google Scholar]
  33. Lange P., Parner J., Vestbo J., Schnohr P., Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998 Oct 22;339(17):1194–1200. doi: 10.1056/NEJM199810223391703. [DOI] [PubMed] [Google Scholar]
  34. Maesen F. P., Smeets J. J., Sledsens T. J., Wald F. D., Cornelissen P. J. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group. Eur Respir J. 1995 Sep;8(9):1506–1513. [PubMed] [Google Scholar]
  35. Man G. C., Champman K. R., Ali S. H., Darke A. C. Sleep quality and nocturnal respiratory function with once-daily theophylline (Uniphyl) and inhaled salbutamol in patients with COPD. Chest. 1996 Sep;110(3):648–653. doi: 10.1378/chest.110.3.648. [DOI] [PubMed] [Google Scholar]
  36. Martin R. J., Banks-Schlegel S. Chronobiology of asthma. Am J Respir Crit Care Med. 1998 Sep;158(3):1002–1007. doi: 10.1164/ajrccm.158.3.9712132. [DOI] [PubMed] [Google Scholar]
  37. Martin R. J., Pak J. Overnight theophylline concentrations and effects on sleep and lung function in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992 Mar;145(3):540–544. doi: 10.1164/ajrccm/145.3.540. [DOI] [PubMed] [Google Scholar]
  38. Ng Man Kwong G., Das C., Proctor A. R., Whyte M. K. B., Primhak R. A. Diagnostic and treatment behaviour in children with chronic respiratory symptoms: relationship with socioeconomic factors. Thorax. 2002 Aug;57(8):701–704. doi: 10.1136/thorax.57.8.701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Nisar M., Walshaw M., Earis J. E., Pearson M. G., Calverley P. M. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease. Thorax. 1990 Mar;45(3):190–194. doi: 10.1136/thx.45.3.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Nish W. A., Schwietz L. A. Underdiagnosis of asthma in young adults presenting for USAF basic training. Ann Allergy. 1992 Sep;69(3):239–242. [PubMed] [Google Scholar]
  41. O'Connor B. J., Towse L. J., Barnes P. J. Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):876–880. doi: 10.1164/ajrccm.154.4.8887578. [DOI] [PubMed] [Google Scholar]
  42. Pincus D. J., Szefler S. J., Ackerson L. M., Martin R. J. Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol. 1995 Jun;95(6):1172–1178. doi: 10.1016/s0091-6749(95)70073-0. [DOI] [PubMed] [Google Scholar]
  43. Postma D. S., Keyzer J. J., Koëter G. H., Sluiter H. J., De Vries K. Influence of the parasympathetic and sympathetic nervous system on nocturnal bronchial obstruction. Clin Sci (Lond) 1985 Sep;69(3):251–258. doi: 10.1042/cs0690251. [DOI] [PubMed] [Google Scholar]
  44. Postma D. S., Koëter G. H., vd Mark T. W., Reig R. P., Sluiter H. J. The effects of oral slow-release terbutaline on the circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstruction. Chest. 1985 May;87(5):653–657. doi: 10.1378/chest.87.5.653. [DOI] [PubMed] [Google Scholar]
  45. Prior J. G., Cochrane G. M. Assessment of optimum dose of inhaled terbutaline in patients with chronic asthma: the use of simple, cumulative dose-response curves. Br J Dis Chest. 1982 Jul;76(3):266–268. [PubMed] [Google Scholar]
  46. Quanjer P. H., Tammeling G. J., Cotes J. E., Pedersen O. F., Peslin R., Yernault J. C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993 Mar;16:5–40. [PubMed] [Google Scholar]
  47. Renwick D. S., Connolly M. J. Prevalence and treatment of chronic airways obstruction in adults over the age of 45. Thorax. 1996 Feb;51(2):164–168. doi: 10.1136/thx.51.2.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Rivington R. N., Calcutt L., Hodder R. V., Stewart J. H., Aitken T. L. Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction. Am J Med. 1988 Jul 29;85(1B):48–53. doi: 10.1016/0002-9343(88)90242-2. [DOI] [PubMed] [Google Scholar]
  49. Rubinfeld A. R., Pain M. C. Perception of asthma. Lancet. 1976 Apr 24;1(7965):882–884. doi: 10.1016/s0140-6736(76)92097-3. [DOI] [PubMed] [Google Scholar]
  50. Ruffin R. E., Wilson D. H., Chittleborough C. R., Southcott A. M., Smith B., Christopher D. J. Multiple respiratory symptoms predict quality of life in chronic lung disease: a population-based study of Australian adults. Qual Life Res. 2000;9(9):1031–1039. doi: 10.1023/a:1016689729722. [DOI] [PubMed] [Google Scholar]
  51. Selim A. J., Ren X. S., Fincke G., Rogers W., Lee A., Kazis L. A symptom-based measure of the severity of chronic lung disease: results from the Veterans Health Study. Chest. 1997 Jun;111(6):1607–1614. doi: 10.1378/chest.111.6.1607. [DOI] [PubMed] [Google Scholar]
  52. Smolensky M. H., McGovern J. P., Scott P. H., Reinberg A. Chronobiology and asthma. II. Body-time-dependent differences in the kinetics and effects of bronchodilator medications. J Asthma. 1987;24(2):91–134. doi: 10.3109/02770908709070926. [DOI] [PubMed] [Google Scholar]
  53. Tashkin D. P., Ashutosh K., Bleecker E. R., Britt E. J., Cugell D. W., Cummiskey J. M., DeLorenzo L., Gilman M. J., Gross G. N., Gross N. J. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study. Am J Med. 1986 Nov 14;81(5A):81–90. doi: 10.1016/0002-9343(86)90468-7. [DOI] [PubMed] [Google Scholar]
  54. Torén K., Brisman J., Järvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest. 1993 Aug;104(2):600–608. doi: 10.1378/chest.104.2.600. [DOI] [PubMed] [Google Scholar]
  55. Turner-Warwick M. Nocturnal asthma: a study in general practice. J R Coll Gen Pract. 1989 Jun;39(323):239–243. [PMC free article] [PubMed] [Google Scholar]
  56. Tweeddale P. M., Alexander F., McHardy G. J. Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax. 1987 Jul;42(7):487–490. doi: 10.1136/thx.42.7.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. de Marco R., Cerveri I., Bugiani M., Ferrari M., Verlato G. An undetected burden of asthma in Italy: the relationship between clinical and epidemiological diagnosis of asthma. Eur Respir J. 1998 Mar;11(3):599–605. [PubMed] [Google Scholar]
  58. van Noord J. A., Bantje T. A., Eland M. E., Korducki L., Cornelissen P. J. A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group. Thorax. 2000 Apr;55(4):289–294. doi: 10.1136/thorax.55.4.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. van Noord J. A., de Munck D. R., Bantje T. A., Hop W. C., Akveld M. L., Bommer A. M. Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. Eur Respir J. 2000 May;15(5):878–885. doi: 10.1034/j.1399-3003.2000.15e11.x. [DOI] [PubMed] [Google Scholar]
  60. van Schayck C. P., van Der Heijden F. M., van Den Boom G., Tirimanna P. R., van Herwaarden C. L. Underdiagnosis of asthma: is the doctor or the patient to blame? The DIMCA project. Thorax. 2000 Jul;55(7):562–565. doi: 10.1136/thorax.55.7.562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. van den Boom G., van Schayck C. P., van Möllen M. P., Tirimanna P. R., den Otter J. J., van Grunsven P. M., Buitendijk M. J., van Herwaarden C. L., van Weel C. Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. Am J Respir Crit Care Med. 1998 Dec;158(6):1730–1738. doi: 10.1164/ajrccm.158.6.9709003. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES